These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25989470)

  • 1. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
    Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
    Solomon DH; Reed GW; Kremer JM; Curtis JR; Farkouh ME; Harrold LR; Hochberg MC; Tsao P; Greenberg JD
    Arthritis Rheumatol; 2015 Jun; 67(6):1449-55. PubMed ID: 25776112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.
    Cacciapaglia F; Fornaro M; Venerito V; Perniola S; Urso L; Iannone F
    Eur J Clin Invest; 2020 Dec; 50(12):e13343. PubMed ID: 32654116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.
    Curtis JR; Xie F; Crowson CS; Sasso EH; Hitraya E; Chin CL; Bamford RD; Ben-Shachar R; Gutin A; Flake DD; Mabey B; Lanchbury JS
    Arthritis Res Ther; 2020 Dec; 22(1):282. PubMed ID: 33276814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
    Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
    Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
    Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
    Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
    Ocon AJ; Reed G; Pappas DA; Curtis JR; Kremer JM
    Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.
    del Rincón ID; Williams K; Stern MP; Freeman GL; Escalante A
    Arthritis Rheum; 2001 Dec; 44(12):2737-45. PubMed ID: 11762933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
    Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
    Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
    Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
    Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.
    Solomon DH; Kremer J; Curtis JR; Hochberg MC; Reed G; Tsao P; Farkouh ME; Setoguchi S; Greenberg JD
    Ann Rheum Dis; 2010 Nov; 69(11):1920-5. PubMed ID: 20444756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis.
    Sasso EH; Mabey B; Flake DD; Hitraya E; Chin CL; Ben-Shachar R; Gutin A; Lanchbury JS; Curtis JR
    PLoS One; 2024; 19(5):e0296459. PubMed ID: 38709770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.